Experiment 1171035

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

SPERGUALIN

Alerts

RESULTS SIGNIFICANT AT P < 0.01 LEVEL.

Details

PropertyValue
Pharmacology
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Administration routeIP
OrganismEmpty organism
CitationUMEZAWA,H: TSHIZUKA,M: TAKEUCHI,T: ABE,F: NEMOTO,K: SHIBUYA,K: NAKAMURA,T:. (1985). SUPPRESSION OF TISSUE GRAFT REJECTION BY SPERGUALIN.. 38(2)
Amount utilized
Compound isolated
Dose amount3.13 MG
Number2
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE